An implantable prosthesis valve device and a method for implanting the same are provided. The device includes a frame body. The frame body includes a valve leaflet fixing portion for fixing prosthetic valve leaflets, and a first fixing portion located at one end portion of a frame. In an axial direction, the frame body further includes a first buffer portion located between the first fixing portion and the valve leaflet fixing portion, and a second buffer portion located between the other end portion of the frame body and the valve leaflet fixing portion, wherein at least one of the first buffer portion and the second buffer portion has an elasticity in the axial direction.

A tissue expander includes a shell having an anterior wall with superior and inferior zones, and one or more drainage openings formed in the inferior zone. A fill port assembly is located within the superior zone, and a drain port assembly is located within the inferior zone and is in fluid communication with the one or more drainage openings. The fill port assembly is isolated from the drain port assembly that is located within the inferior zone. The drain port assembly includes a drain cover having an elongated body, a central hub, one or more fluid reservoirs between the first and second ends of the elongated body, and an outer face that surrounds the fluid reservoirs. The outer face of the drain cover is secured to an inner surface of the anterior wall and surrounds the one or more drainage openings formed in the inferior zone of the shell.

A material includes a metallic, nanoporous structure having a plurality of nanopores having a porosity that allows passage of insulin but not IgG. The metallic nanoporous structure includes titanium, 316L stainless steel and may have a textured nano-sericeous surface. A nanoporous bicontinuous structure can be integrated with nanopores.

A prosthetic implant, such as a tissue expander, includes a silicone shell having an anterior wall and a posterior wall, and a needle stop patch secured over an inner surface of the posterior wall of the silicone shell. The needle stop patch has two or more layers of a textile material that are stacked atop one another. The textile material is flexible and includes woven threads or fiber. A bonding material bonds together the two or more layers of the textile material that are stacked atop one another. The outer edges of the respective layers are feathered for minimizing step effects between adjacent ones of the layers. A self-sealing membrane covers the anterior wall of the silicone shell. The dernier level of the textile layers increases between top and bottom layers for progressively increasing resistance tom a needle passing through the needle stop patch.

Disclosed is a self-expandable atrioventricular valve prosthesis device, including a main body portion of a frame structure, wherein the main body portion is implanted at a primary annulus of a heart and the main body portion includes an inflow segment, an outflow segment and a transition segment, wherein the inflow segment is located at an atrium end, the outflow segment is located at a ventricle end, and the transition segment is located between the inflow segment and the outflow segment. The device further includes at least one prosthetic valve leaflet fixed to the transition segment of the main body portion, and the prosthetic valve leaflet is configured with a connecting portion. The device further includes a chordae tendineae portion with one end fixed and the other end connected to the prosthetic valve leaflet via the connecting portion. In the present invention, by limiting the movement range of the prosthetic valve leaflet via the chordae tendineae portion, and by preventing the shear stress and the stress concentration on the valve leaflets exerted by the chordae tendineae portion via the connecting portion, the endurance of the prosthetic valve leaflet is increased.

Packaging for a breast implant, the packaging comprising a lid and a cavity, wherein one of the lid or the cavity is configured to provide direct delivery of the breast implant from the packaging to a surgical pocket. A method for the direct delivery of a breast implant from breast implant packaging to a surgical pocket, the method comprising the steps of: a. ensuring that a delivery device present in a lid or a cavity of the packaging is in a delivery position; b. forming an aperture in the delivery device, thereby opening the packaging; c. transferring the breast implant to the delivery device; d. positioning the delivery device in contact with the surgical pocket; and e. delivering the breast implant to the surgical pocket.

A luminal stent includes a tube body that can be compressed and expanded in the radial direction, and an anti-leakage structure. The tube body is divided by the anti-leakage structure into a first tube body positioned on one side of the anti-leakage structure, and a second tube body positioned on the other side of the anti-leakage structure, with at least part of the first tube body being encircled by the anti-leakage structure. In a compressed state, the maximum compression diameter of the anti-leakage structure and the first tube body encircled by the anti-leakage structure is greater than or equal to the maximum compression diameter of the second tube body.

A transcatheter prosthesis includes a stent, a prosthetic valve component, and an anti-paravalvular leakage component. The anti-paravalvular leakage component is coupled to the stent and includes an inner skirt, an outer wrap, a cavity, an opening, and a one-way valve. The inner skirt is disposed on an inner surface of the stent and has an inflow end and a downstream end. The outer wrap is disposed around an outer surface of the stent and has an inflow end coupled to the inflow end of the inner skirt and a downstream end. The cavity is formed between an outer surface of the inner skirt and an inner surface of the outer wrap. An opening is disposed between the inner skirt and the outer wrap. The one-way valve includes a flap at the opening configured to open to allow blood flow into the cavity but prevent blood flow out of the cavity.

Methods of delivering a prosthetic aortic heart valve are disclosed. The disclosed methods include loading a prosthetic aortic valve in a collapsed configuration into a delivery sheath so that a selected point on the prosthetic valve is rotationally aligned relative to a long axis of the delivery sheath with a selected radiopaque marker on the delivery sheath, while under fluoroscopic imaging, rotating the delivery sheath about its long axis to align a selected radiopaque marker on the delivery sheath with the selected point on the native aortic valve in a fluoroscopic imaging plane, thereby establishing a desired orientation of the prosthetic aortic valve with respect to the native aortic valve in which the prosthetic valve commissures are rotationally aligned with commissures of the native aortic valve, further advancing the delivery sheath along its long axis until the prosthetic aortic valve is disposed inside the native aortic valve, and deploying the prosthetic aortic valve into an implanted state inside the native aortic valve with the prosthetic aortic valve aligned in the desired orientation with respect to the native aortic valve.

The present disclosure relates to valve replacement devices that are foldable for catheter-based deployment to the site of implantation, as well as systems for the delivery of valve prostheses, including prostheses having the special characteristics of the disclosed valve replacement devices. The devices include highly effective adhering mechanisms for secure and enduring precision implantation. The adhering mechanisms may employ a unique sealing mechanism that includes a cuff that expands slowly whereby the device is not secured in place until the completion of the implantation procedure. The implanted device, optionally together with the cuff, prevents perivalvular leaks and incorporate an appropriate leaflet system for reliable functioning in situ.